{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:24:26Z","timestamp":1790501066432,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.semarthrit.2019.09.008","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T05:12:37Z","timestamp":1584335557000},"page":"335-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Characteristics and outcomes of patients with ophthalmologic involvement in giant-cell arteritis: A case-control study"],"prefix":"10.1016","volume":"50","author":[{"given":"Ana\u00ebl","family":"Dumont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Lecannuet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Boutemy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gw\u00e9nola","family":"Maign\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Martin-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Deshayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Audemard-Verger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00e9tane","family":"Planchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Aouba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"de Boysson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2019.09.008_bib0001","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.1780240706","article-title":"The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications","volume":"24","author":"Bengtsson","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0002","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/rheumatology\/kex428","article-title":"Ophthalmic manifestations of giant cell arteritis","volume":"57","author":"Vodopivec","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0003","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/md.0b013e31803d1764","article-title":"Giant cell arteritis in northwestern Spain : a 25-year epidemiologic study","volume":"86","author":"Gonzalez-Gay","year":"2007","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0004","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.160466","article-title":"Giant cell arteritis: visual loss is our major concern","volume":"43","author":"Gonzalez-Gay","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0005","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.ophtha.2016.05.008","article-title":"Evaluating the incidence of arteritic ischemic optic neuropathy and other causes of vision loss from giant cell arteritis","volume":"123","author":"Chen","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0006","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0007","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ophtha.2005.01.036","article-title":"Poor prognosis of visual outcome after visual loss from giant cell arteritis","volume":"112","author":"Danesh-Meyer","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0008","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","article-title":"Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients","volume":"111","author":"Liozon","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0009","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/art.21075","article-title":"Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis","volume":"53","author":"Salvarani","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0011","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3899\/jrheum.140188","article-title":"Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort","volume":"42","author":"Singh","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0012","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients","volume":"79","author":"Gonzalez-Gay","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0013","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American college of rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0014","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1007\/s10067-018-4244-6","article-title":"Giant cell arteritis presenting as isolated inflammatory response and\/or fever of unknown origin: a case-control study","volume":"37","author":"de Boysson","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2017.11.029","article-title":"Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients","volume":"17","author":"de Boysson","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0016","article-title":"Factors associated with relapse and dependence to glucocorticoids in giant-cell arteritis","author":"Dumont","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0017","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3899\/jrheum.161033","article-title":"Giant cell arteritis-related stroke: a retrospective multicenter case-control study","volume":"44","author":"de Boysson","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0018","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MD.0b013e3181af4518","article-title":"Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis","volume":"88","author":"Gonzalez-Gay","year":"2009","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0019","first-page":"524","article-title":"The association of vascular risk factors with visual loss in giant cell arteritis","volume":"56","author":"Yates","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0020","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(94)31102-X","article-title":"Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision","volume":"101","author":"Liu","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0021","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/sarh.2001.16650","article-title":"Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy","volume":"30","author":"Gonzalez-Gay","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0022","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semarthrit.2007.10.014","article-title":"The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis","volume":"38","author":"Lopez-Diaz","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0023","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.revmed.2015.12.015","article-title":"Management of giant cell arteritis: recommendations of the French study group for large vessel vasculitis (GEFA)","volume":"37","author":"Bienvenu","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0024","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","article-title":"BSR and BHPR guidelines for the management of giant cell arteritis","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1034\/j.1600-0420.2002.800403.x","article-title":"Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature","volume":"80","author":"Hayreh","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0026","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0161-6420(03)00228-8","article-title":"Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy","volume":"110","author":"Hayreh","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0027","doi-asserted-by":"crossref","first-page":"e3210","DOI":"10.1097\/MD.0000000000003210","article-title":"Do early diagnosis and glucocorticoid treatment decrease the risk of permanent visual loss and early relapses in giant cell arteritis: a prospective longitudinal study","volume":"95","author":"Hocevar","year":"2016","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.09.008_bib0028","first-page":"104","article-title":"A probability score to aid the diagnosis of suspected giant cell arteritis","volume":"37 Suppl 117","author":"Laskou","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0029","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/kev289","article-title":"The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis","volume":"55","author":"Diamantopoulos","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2019.09.008_bib0030","first-page":"S103","article-title":"Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study","volume":"33","author":"Patil","year":"2015","journal-title":"Clin Exp Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017219306432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017219306432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:02:45Z","timestamp":1758733365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017219306432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0049017219306432"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2019.09.008","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and outcomes of patients with ophthalmologic involvement in giant-cell arteritis: A case-control study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2019.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}